Employees are coming forward, claiming the company laid them off and hasn't paid them for their last few weeks of work.

Although existing CRISPR-Cas-based imaging methods can target endogenous genomic sequences, their applications are limited by ...

Company confirms 12 patients enrolled in Phase 2 THIO-101 to date as expansion trial adds new countries Posters for Phase 2 and Phase 3 clinical trials available CHICAGO, Nov. 21, 2025 (GLOBE NEWSWIRE ...

THE Philippines is on the cusp of a biotechnological revolution, with the potential to transform the country's agriculture, food security, and public health. A recent forum in Manila brought together ...

Rewriting the rules, the innovative biotech company is now preparing for its next stage of growth and is offering Employment ...

The posters presented at SITC 2025 feature trial designs for the Phase 2 and Phase 3 studies in advanced NSCLC patients receiving ateganosine followed by a checkpoint inhibitor, cemiplimab (Libtayo®).

Blue Lake Biotechnology, Inc., a clinical-stage intranasal vaccine company developing parainfluenza virus 5 (PIV5)-vectored vaccines that harness the full breadth of the immune system to protect ...

A jobs report and tight policy are shifting attention to defensive areas, making healthcare mutual funds like FBDIX, FBTIX and JNGLX appear more resilient.

Shares of Contineum Therapeutics dipped by the double-digits late Thursday after investors learned of a clinical setback for ...

Global Biotech is surging as policy fears fade and innovation takes centre stage. Here’s what’s driving the comeback into ...

Kristen Waddell has spent more than a year using new techniques to study water quality in South Texas, using samples ...

That starts with leadership from our policymakers. They must protect the foundation of all progress: federal support for ...